Menu Search
Equities

Envista Holdings Corp

0HV:BER

Envista Holdings Corp

Actions
  • Price (EUR)19.00
  • Today's Change-1.00 / -5.00%
  • Shares traded--
  • 1 Year change-6.36%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 20:48 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.

  • Revenue in USD (TTM)2.50bn
  • Net income in USD-1.34bn
  • Incorporated2018
  • Employees12.80k
  • Location
    Envista Holdings Corp200 S. Kraemer Blvd., Bldg. EBREA 92821United StatesUSA
  • Phone+1 (714) 817-5418
  • Fax+1 (302) 655-5049
  • Websitehttps://envistaco.com/en
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.